abbvie glp-1 receptor agonists weight management diabetes treatments Optimizing therapies for obesity and Indications for GLP-1/GIP RA Summary
Description
doi: 10.1111/dom.14551
(2014) and Bruinstroop et al
Missed doses and frequent medication switches can affect side effects and stability during screening
And for Medicaid patients who need GLP-1 medications, Pennsylvania is one of 13 states nationwide that allows approval for the treatment of obesity
Development of new therapies for the treatment of diabetes continues to focus on enhancing the positive effects of GLP-1
Food Bioactives and Nutraceuticals: Dietary Medicine for Human Health and Well-Beings
